Data as of Jul 25
| -0.48 / -1.57%|
The 9 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 42.00, with a high estimate of 70.00 and a low estimate of 10.00. The median estimate represents a +39.35% increase from the last price of 30.14.
The current consensus among 10 polled investment analysts is to Buy stock in Isis Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.